PMS18 COST-EFFECTIVENESS OF TOFACITINIB FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1128
https://www.valueinhealthjournal.com/article/S1098-3015(19)31320-8/fulltext
Title :
PMS18 COST-EFFECTIVENESS OF TOFACITINIB FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31320-8&doi=10.1016/j.jval.2019.04.1128
First page :
Section Title :
Open access? :
No
Section Order :
10652